These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21605099)

  • 1. Haem arginate as effective maintenance therapy for hereditary coproporphyria.
    Ma E; Mar V; Varigos G; Nicoll A; Ross G
    Australas J Dermatol; 2011 May; 52(2):135-8. PubMed ID: 21605099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute attacks of hepatic porphyria: specific treatment with heme arginate].
    Nordmann Y; Deybach JC
    Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients.
    Kühnel A; Gross U; Doss MO
    Clin Biochem; 2000 Aug; 33(6):465-73. PubMed ID: 11074238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P; Nordmann Y
    Arch Intern Med; 1993 Sep; 153(17):2004-8. PubMed ID: 8357285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of haem arginate in acute hepatic porphyria.
    Herrick AL; McColl KE; Moore MR; Cook A; Goldberg A
    Lancet; 1989 Jun; 1(8650):1295-7. PubMed ID: 2566827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haem arginate in acute hereditary coproporphyria.
    Manning DJ; Gray TA
    Arch Dis Child; 1991 Jun; 66(6):730-1. PubMed ID: 2053800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between uroporphyrin excretion, acute attacks of hereditary coproporphyria and successful treatment with haem arginate.
    Schoenfeld N; Mamet R; Dotan I; Sztern M; Levo Y; Aderka D
    Clin Sci (Lond); 1995 Mar; 88(3):365-9. PubMed ID: 7736708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood.
    Brodie MJ; Thompson GG; Moore MR; Beattie AD; Goldberg A
    Q J Med; 1977 Apr; 46(182):229-41. PubMed ID: 866576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Tokola O; Lindén IB; Tenhunen R
    Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haem arginate on variegate porphyria.
    Timonen K; Mustajoki P; Tenhunen R; Lauharanta J
    Br J Dermatol; 1990 Sep; 123(3):381-7. PubMed ID: 2206975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias.
    Kostrzewska E; Gregor A; Tarczyńska-Nosal S
    Mater Med Pol; 1991; 23(4):259-62. PubMed ID: 1842231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute intermittent porphyria: a diagnostic dilemma].
    Gázquez Sisteré I; Luján Mavila K; Chordá Ribelles J; Touzón López C
    Gastroenterol Hepatol; 2010; 33(6):436-9. PubMed ID: 20435380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary coproporphyria (Hepatic coproporphyria), Erythropoietic coproporphyria].
    Kiso S; Kawata S; Kashihara T; Tamura S; Matsuzawa Y
    Nihon Rinsho; 1995 Jun; 53(6):1433-7. PubMed ID: 7616659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haem arginate as a treatment for myelodysplastic syndromes.
    Ruutu T; Volin L; Tenhunen R
    Br J Haematol; 1987 Apr; 65(4):425-8. PubMed ID: 3580298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practice guidelines on clinical management of acute attacks of porphyria and their complications.
    Stein P; Badminton M; Barth J; Rees D; Stewart MF;
    Ann Clin Biochem; 2013 May; 50(Pt 3):217-23. PubMed ID: 23605132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute porphyria: treatment with heme.
    Tenhunen R; Mustajoki P
    Semin Liver Dis; 1998; 18(1):53-5. PubMed ID: 9516678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of haem arginate therapy on porphyrin metabolism and mixed function oxygenase activity in acute hepatic porphyria.
    Herrick A; McColl KE; McLellan A; Moore MR; Brodie MJ; Goldberg A
    Lancet; 1987 Nov; 2(8569):1178-9. PubMed ID: 2890809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute and cutaneous porphyrias.
    Badminton MN; Elder GH
    Int J Clin Pract; 2002 May; 56(4):272-8. PubMed ID: 12074210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.